{"title":"LACC1 Promoted Nerve Injury in an Anesthesia-Induced Cognitive Disorder Model via RIP2 Expression through ROS-NOD2 Induction.","authors":"Kai Lu, Yadong Li, Haiwei Xiao","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to investigate the impact of laccase domain-containing 1 (LACC1) on the model of anesthesia-induced cognitive disorder and its underlying mechanisms.</p><p><strong>Methods: </strong>We collected and analyzed data from 24 patients with postoperative cognitive dysfunction (POCD) through microarray analysis. In the animal model, mice were exposed to 1.3% isoflurane in a humidified atmosphere with 30% oxygen as the carrier gas. Additionally, PC12 cells were stimulated with 2% isoflurane.</p><p><strong>Results: </strong>In mice subjected to anesthesia, both mRNA and protein expression levels of LACC1 were up-regulated. Moreover, LACC1 expression was increased in the anesthesia-induced cognitive disorder model. In vitro, LACC1 promoted the production of reactive oxygen species (ROS). Furthermore, LACC1 was found to exacerbate cognitive impairment in mice under anesthesia. The induction of RIP2 expression mediated this effect via the ROS-NOD2 pathway. The regulation of ROS-NOD2 played a critical role in controlling the impacts of LACC1 in both in vivo and in vitro models.</p><p><strong>Conclusions: </strong>Our findings demonstrate that LACC1 contributes to nerve injury in the anesthesia-induced cognitive disorder model by inhibiting the ROS-NOD2/RIP2 signaling pathway. This discovery offers a novel perspective for understanding anesthesia-induced cognitive disorders.</p>","PeriodicalId":7571,"journal":{"name":"Alternative therapies in health and medicine","volume":null,"pages":null},"PeriodicalIF":1.9000,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alternative therapies in health and medicine","FirstCategoryId":"3","ListUrlMain":"","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"INTEGRATIVE & COMPLEMENTARY MEDICINE","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: This study aimed to investigate the impact of laccase domain-containing 1 (LACC1) on the model of anesthesia-induced cognitive disorder and its underlying mechanisms.
Methods: We collected and analyzed data from 24 patients with postoperative cognitive dysfunction (POCD) through microarray analysis. In the animal model, mice were exposed to 1.3% isoflurane in a humidified atmosphere with 30% oxygen as the carrier gas. Additionally, PC12 cells were stimulated with 2% isoflurane.
Results: In mice subjected to anesthesia, both mRNA and protein expression levels of LACC1 were up-regulated. Moreover, LACC1 expression was increased in the anesthesia-induced cognitive disorder model. In vitro, LACC1 promoted the production of reactive oxygen species (ROS). Furthermore, LACC1 was found to exacerbate cognitive impairment in mice under anesthesia. The induction of RIP2 expression mediated this effect via the ROS-NOD2 pathway. The regulation of ROS-NOD2 played a critical role in controlling the impacts of LACC1 in both in vivo and in vitro models.
Conclusions: Our findings demonstrate that LACC1 contributes to nerve injury in the anesthesia-induced cognitive disorder model by inhibiting the ROS-NOD2/RIP2 signaling pathway. This discovery offers a novel perspective for understanding anesthesia-induced cognitive disorders.
期刊介绍：
Launched in 1995, Alternative Therapies in Health and Medicine has a mission to promote the art and science of integrative medicine and a responsibility to improve public health. We strive to maintain the highest standards of ethical medical journalism independent of special interests that is timely, accurate, and a pleasure to read. We publish original, peer-reviewed scientific articles that provide health care providers with continuing education to promote health, prevent illness, and treat disease. Alternative Therapies in Health and Medicine was the first journal in this field to be indexed in the National Library of Medicine. In 2006, 2007, and 2008, ATHM had the highest impact factor ranking of any independently published peer-reviewed CAM journal in the United States—meaning that its research articles were cited more frequently than any other journal’s in the field.
Alternative Therapies in Health and Medicine does not endorse any particular system or method but promotes the evaluation and appropriate use of all effective therapeutic approaches. Each issue contains a variety of disciplined inquiry methods, from case reports to original scientific research to systematic reviews. The editors encourage the integration of evidence-based emerging therapies with conventional medical practices by licensed health care providers in a way that promotes a comprehensive approach to health care that is focused on wellness, prevention, and healing. Alternative Therapies in Health and Medicine hopes to inform all licensed health care practitioners about developments in fields other than their own and to foster an ongoing debate about the scientific, clinical, historical, legal, political, and cultural issues that affect all of health care.
分享
京公网安备 11010802042870号
京ICP备2023020795号-1
求助内容：
应助结果提醒方式：
扫码关注我们
